Synthetic Biology Inspired Medicines
We design and engineer microbial strains rationally to manufacture or as medicines for infectious diseases, cancer and beyond
Discover more
Delonix is a world leading biotech company dedicated to the design and engineering of microbes for medicines.
Founded by experts in synthetic biology, vaccinology and cancer immunotherapies, Delonix holds the ambition to reform the way we develop and manufacture medicines to address global health challenges.
What We Are Doing
Accelerated
Manufacture of Medicines
Inspired by nature, adjuvant molecules, polysaccharide protein conjugates, and diverse antigens are refined and biosynthesized efficiently within a cell, driving process simplification and product innovation.
Synthetic
Vaccines
Driven by rational design, we engineer bacteria to perform desired functions, transforming pathogens into live vaccine vectors and biosubstance into protective agents to tackle intractable bacterial infections.
Synthetic
Cancer Therapies
Bacteria harness the power of tumor cell lysis and immune stimulation. Applying synthetic biology approach, we redesign bacteria to target solid tumors and deliver various therapeutic payloads, precisely and continuously.
01
Synthetic Biology
Platform
  • Complete toolkits for non-model microbe engineering
  • Data-driven rational design
  • High throughput & automation


02
Vaccine Technology
Platform
  • Surfomics and reverse vaccinology for efficient antigen discovery
  • Immune checkpoints for vaccine development
  • Various in vivo infection models


What's happening about us?
  • Delonix Bioworks Wins Boehringer Ingelheim’s Innovation Prize in 2020
    Oct 10, 2021
  • Delonix Bioworks Closes $14 Million Series Seed Financingto Accelerate the Development of its Innovative Synthetic Vaccines
    Oct 10, 2021
  • $14 Million Series Seed Financingto Accelerate the Development of its Innovative Synthetic Vaccines
    Oct 10, 2021
  • Delonix Bioworks Wins Boehringer Ingelheim’s Innovation Prize in 2020
    Oct 10, 2021
  • Delonix Bioworks Wins Boehringer Ingelheim’s Innovation Prize in 2020
    Oct 10, 2021